Farnesoid X Receptor Activation Enhances Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells

Autor: Makoto Makishima, Keiji Sano, Masahiko Kainuma, Ichiro Takada
Rok vydání: 2018
Předmět:
0301 basic medicine
Receptors
Cytoplasmic and Nuclear

epithelial–mesenchymal transition
lcsh:Chemistry
chemistry.chemical_compound
Chenodeoxycholic acid
Receptor
transforming growth factor β
lcsh:QH301-705.5
Spectroscopy
Bile acid
Liver Neoplasms
Obeticholic acid
General Medicine
hepatocellular carcinoma
Cadherins
Computer Science Applications
Gene Expression Regulation
Neoplastic

Liver
Carcinoma
Hepatocellular

Epithelial-Mesenchymal Transition
medicine.drug_class
guggulsterone
Chenodeoxycholic Acid
Catalysis
Article
Inorganic Chemistry
Bile Acids and Salts
Transforming Growth Factor beta1
03 medical and health sciences
Cell Line
Tumor

medicine
Humans
bile acid
Epithelial–mesenchymal transition
Physical and Theoretical Chemistry
Molecular Biology
N-cadherin
Organic Chemistry
focal adhesion kinase
Isoxazoles
digestive system diseases
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
chemistry
Cancer research
Farnesoid X receptor
Guggulsterone
farnesoid X receptor
Transforming growth factor
Zdroj: International Journal of Molecular Sciences
Volume 19
Issue 7
International Journal of Molecular Sciences, Vol 19, Iss 7, p 1898 (2018)
ISSN: 1422-0067
Popis: Farnesoid X receptor (FXR) is a receptor for bile acids and plays an important role in the regulation of bile acid metabolism in the liver. Although FXR has been shown to affect hepatocarcinogenesis through both direct and indirect mechanisms, potential roles of FXR in epithelial&ndash
mesenchymal transition (EMT) in hepatocellular carcinoma (HCC) remain unclear. We examined the effect of several FXR ligands on EMT-related morphological changes in HCC cell lines, such as HuH-7 and Hep3B cells. FXR agonists (chenodeoxycholic acid, GW4064, and obeticholic acid)&mdash
but not an antagonist (guggulsterone)&mdash
induced actin polymerization and expression of N-cadherin and phosphorylated focal adhesion kinase, although they were less effective than transforming growth factor &beta
(TGF-&beta
). FXR agonist treatment enhanced TGF-&beta
induced EMT morphologic changes and FXR antagonist inhibited the effect of TGF-&beta
Thus, FXR activation enhances EMT in HCC and FXR antagonists may be EMT-suppressing drug candidates.
Databáze: OpenAIRE